Diastolic leading to systolic anterior motion: new technology reveals physiology.
作者信息
Levine Robert A, Schwammenthal Ehud, Song Jae-Kwan
机构信息
Cardiac Ultrasound Laboratory, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Heart Institute, Chaim Sheba Medical Center, Tel Hashomer, Tel Aviv University, Tel Aviv, Israel.
出版信息
J Am Coll Cardiol. 2014 Nov 11;64(19):1996-9. doi: 10.1016/j.jacc.2014.09.010. Epub 2014 Nov 3.
Abstract
摘要
相似文献
1
Diastolic leading to systolic anterior motion: new technology reveals physiology.
J Am Coll Cardiol. 2014 Nov 11;64(19):1996-9. doi: 10.1016/j.jacc.2014.09.010. Epub 2014 Nov 3.
2
The Strain, the Valve, and the LVOT Obstruction.
J Am Coll Cardiol. 2015 May 12;65(18):2050. doi: 10.1016/j.jacc.2015.01.057.
3
Reply: The Strain, the Valve, and the LVOT Obstruction.
J Am Coll Cardiol. 2015 May 12;65(18):2051. doi: 10.1016/j.jacc.2015.02.056.
4
Vector flow mapping in obstructive hypertrophic cardiomyopathy to assess the relationship of early systolic left ventricular flow and the mitral valve.
J Am Coll Cardiol. 2014 Nov 11;64(19):1984-95. doi: 10.1016/j.jacc.2014.04.090. Epub 2014 Nov 3.
5
Systolic anterior motion of the posterior leaflet in hypertrophic cardiomyopathy.
Echocardiography. 2014 Apr;31(4):E128-9. doi: 10.1111/echo.12480. Epub 2013 Dec 17.
6
Systolic anterior motion of the mitral valve--beyond hypertrophic cardiomyopathy.
Heart. 2008 Nov;94(11):1383-5. doi: 10.1136/hrt.2007.122069.
7
Abnormalities of the Mitral Apparatus in Hypertrophic Cardiomyopathy: Echocardiographic, Pathophysiologic, and Surgical Insights.
J Am Soc Echocardiogr. 2016 Jul;29(7):622-39. doi: 10.1016/j.echo.2016.03.003. Epub 2016 Apr 14.
8
Echocardiographic assessment of systolic anterior motion of the mitral valve.
Anesth Analg. 2014 Jun;118(6):1197-201. doi: 10.1213/ANE.0000000000000196.
9
The mitral valve in hypertrophic cardiomyopathy: it's a long story.
Circulation. 2011 Jul 5;124(1):9-12. doi: 10.1161/CIRCULATIONAHA.111.035568.
10
Clinical features of the systolic anterior motion of the mitral valve among patients without hypertrophic cardiomyopathy.
J Cardiol. 2017 Feb;69(2):495-500. doi: 10.1016/j.jjcc.2016.04.004. Epub 2016 May 27.
引用本文的文献
1
The clinical utility of cardiac myosin inhibitors for the management of hypertrophic cardiomyopathy: a scoping review.
Heart Fail Rev. 2025 Mar;30(2):453-467. doi: 10.1007/s10741-024-10476-w. Epub 2024 Dec 17.
2
Systolic anterior motion of the anterior mitral valve leaflet begins in subclinical hypertrophic cardiomyopathy.
Eur Heart J Cardiovasc Imaging. 2023 Dec 21;25(1):86-94. doi: 10.1093/ehjci/jead186.
3
Systolic anterior motion of the mitral valve in hypertrophic cardiomyopathy: a narrative review.
J Thorac Dis. 2022 Jun;14(6):2309-2325. doi: 10.21037/jtd-22-182.
4
Successful MitraClip Implantation in a Barlow's Valve: A Feasible Alternative?
CASE (Phila). 2020 Nov 21;5(1):73-77. doi: 10.1016/j.case.2020.10.011. eCollection 2021 Feb.
5
The mechanisms, diagnosis and management of mitral regurgitation in mitral valve prolapse and hypertrophic cardiomyopathy.
Discoveries (Craiova). 2016 Jun 30;4(2):e61. doi: 10.15190/d.2016.8.
6
Management of systolic anterior motion of the mitral valve: a mechanism-based approach.
Gen Thorac Cardiovasc Surg. 2018 Jul;66(7):379-389. doi: 10.1007/s11748-018-0915-0. Epub 2018 Apr 3.
7
Hypertrophic Cardiomyopathy-Past, Present and Future.
J Clin Med. 2017 Dec 12;6(12):118. doi: 10.3390/jcm6120118.
8
Mitral valve disease--morphology and mechanisms.
Nat Rev Cardiol. 2015 Dec;12(12):689-710. doi: 10.1038/nrcardio.2015.161. Epub 2015 Oct 20.
本文引用的文献
1
Vector flow mapping in obstructive hypertrophic cardiomyopathy to assess the relationship of early systolic left ventricular flow and the mitral valve.
J Am Coll Cardiol. 2014 Nov 11;64(19):1984-95. doi: 10.1016/j.jacc.2014.04.090. Epub 2014 Nov 3.
2
Predictors of long-term outcomes in symptomatic hypertrophic obstructive cardiomyopathy patients undergoing surgical relief of left ventricular outflow tract obstruction.
Circulation. 2013 Jul 16;128(3):209-16. doi: 10.1161/CIRCULATIONAHA.112.000849. Epub 2013 Jun 14.
3
Survival after alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
Circulation. 2012 Nov 13;126(20):2374-80. doi: 10.1161/CIRCULATIONAHA.111.076257. Epub 2012 Oct 17.
4
Multiplanar visualization of blood flow using echocardiographic particle imaging velocimetry.
JACC Cardiovasc Imaging. 2012 May;5(5):566-9. doi: 10.1016/j.jcmg.2011.09.026.
5
The mitral valve in hypertrophic cardiomyopathy: old versus new concepts.
J Cardiovasc Transl Res. 2011 Dec;4(6):757-66. doi: 10.1007/s12265-011-9319-6. Epub 2011 Sep 10.
6
Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy.
Circulation. 2011 Jul 5;124(1):40-7. doi: 10.1161/CIRCULATIONAHA.110.985812. Epub 2011 Jun 13.
7
In vivo measurement of mitral leaflet surface area and subvalvular geometry in patients with asymmetrical septal hypertrophy: insights into the mechanism of outflow tract obstruction.
Circulation. 2010 Sep 28;122(13):1298-307. doi: 10.1161/CIRCULATIONAHA.109.935551. Epub 2010 Sep 13.
8
A new concept for correction of systolic anterior motion and mitral valve regurgitation in patients with hypertrophic obstructive cardiomyopathy.
J Thorac Cardiovasc Surg. 2010 Aug;140(2):481-3. doi: 10.1016/j.jtcvs.2010.01.010. Epub 2010 Mar 25.
9
Long-term outcome of alcohol septal ablation in patients with obstructive hypertrophic cardiomyopathy: a word of caution.
Circ Heart Fail. 2010 May;3(3):362-9. doi: 10.1161/CIRCHEARTFAILURE.109.862359. Epub 2010 Mar 23.
10
Developmental origins of hypertrophic cardiomyopathy phenotypes: a unifying hypothesis.
Nat Rev Cardiol. 2009 Apr;6(4):317-21. doi: 10.1038/nrcardio.2009.9.
Zotero 插件